- Home
- TECH
TECH
Bio-Techne Corp
as 07-26-2024 4:00pm EST
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
| Founded: | 1976 | Country: | United States |
| Employees: | N/A | City: | MINNEAPOLIS |
| Market Cap: | 12.2B | IPO Year: | 1989 |
| Target Price: | $81.11 | AVG Volume (30 days): | 1.0M |
| Analyst Decision: | Buy | Number of Analysts: | 10 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 1.25 | EPS Growth: | -25.15 |
| 52 Week Low/High: | $51.79 - $85.85 | Next Earning Date: | 08-07-2024 |
| Revenue: | $1,154,281,000 | Revenue Growth: | 2.73% |
| Revenue Growth (this year): | 3.99% | Revenue Growth (next year): | 7.70% |
Stock Insider Trading Activity of Bio-Techne Corp (TECH)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| HIGGINS JOHN L | TECH | Director | May 14 '24 | Sell | $83.84 | 4,000 | $335,377.20 | 36,608 | SEC Form 4 |
| Nusse Roeland | TECH | Director | Mar 7 '24 | Sell | $76.98 | 10,400 | $800,627.36 | 43,097 | SEC Form 4 |
Latest Bio-Techne Corp News
TECH Breaking Stock News: Dive into TECH Ticker-Specific Updates for Smart Investing
MT Newswires
8 days ago
Leerink Partners Adjusts Price Target on Bio-Techne to $90 From $95
PR Newswire
12 days ago
BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 7, 2024, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2024 FINANCIAL RESULTS
Morningstar Research
14 days ago
Analyst Report: Bio-Techne Corporation
Morningstar Research
24 days ago
Analyst Report: Bio-Techne Corporation
Simply Wall St.
a month ago
Declining Stock and Decent Financials: Is The Market Wrong About Bio-Techne Corporation (NASDAQ:TECH)?
Business Insider
2 months ago
US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia
Insider Monkey
2 months ago
The Best Woody Perfume For Women
Reuters
2 months ago
Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase
Compare TECH vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "TECH Bio-Techne Corp - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.